Louis Moore Bacon's ELV Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 65,000 shares of Elevance Health, Inc. (ELV) worth $22.79 M, representing 0.33% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 129,919 shares. Largest reduction occurred in Q3 2015, reducing 108,216 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +35,026 | Add 116.85% | 65,000 | $350.55 |
| Q3 2025 | +17,953 | Add 149.35% | 29,974 | $323.12 |
| Q2 2025 | -14,521 | Reduce 54.71% | 12,021 | $388.96 |
| Q1 2025 | +25,528 | Add 2517.55% | 26,542 | $434.96 |
| Q4 2024 | -38,986 | Reduce 97.46% | 1,014 | $368.90 |
| Q3 2024 | +20,000 | Add 100.00% | 40,000 | $520.00 |
| Q2 2024 | +20,000 | New Buy | 20,000 | $541.86 |
| Q2 2023 | -1,000 | Sold Out | 0 | $0.00 |
| Q1 2023 | +1,000 | New Buy | 1,000 | $459.81 |
| Q2 2022 | -24,434 | Sold Out | 0 | $0.00 |
| Q1 2022 | +24,434 | New Buy | 24,434 | $491.20 |
| Q1 2021 | -33,909 | Sold Out | 0 | $0.00 |
| Q4 2020 | +33,909 | New Buy | 33,909 | $321.09 |
| Q4 2015 | -35,000 | Sold Out | 0 | $0.00 |
| Q3 2015 | -108,216 | Reduce 75.56% | 35,000 | $140.00 |
| Q2 2015 | +129,919 | Add 977.05% | 143,216 | $164.14 |
| Q1 2015 | +13,297 | New Buy | 13,297 | $154.40 |
Louis Moore Bacon's Elevance Health Investment FAQs
Louis Moore Bacon first purchased Elevance Health, Inc. (ELV) in Q1 2015, acquiring 13,297 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Elevance Health, Inc. (ELV) for 17 quarters since Q1 2015.
Louis Moore Bacon's largest addition to Elevance Health, Inc. (ELV) was in Q2 2015, adding 143,216 shares worth $23.51 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 65,000 shares of Elevance Health, Inc. (ELV), valued at approximately $22.79 M.
As of the Q4 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.33% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Elevance Health, Inc. (ELV) was 143,216 shares, as reported at the end of Q2 2015.